The world of cancer detection and particle physics is poised for a potential paradigm shift as Italian-American scientist Dario Crosetto prepares to present his groundbreaking inventions at the upcoming IEEE Nuclear Science Symposium and Medical Imaging Conference (IEEE-NSS-MIC-RTSD) in Tampa, Florida. Scheduled for October 31, 2024, Crosetto’s presentation will showcase his 3D-Flow and 3D-CBS (3-D Complete Body Screening) technologies, which promise to revolutionize both particle detection and early cancer diagnosis.
Crosetto’s inventions claim to offer superior flexibility, performance, and cost-effectiveness compared to current technologies in the field. The 3D-CBS technology is reported to be capable of detecting tumors with as few as 100 cancer cells, a significant improvement over current methods like CT, MRI, and mammograms, which typically require around 1,000,000 cells for detection. This advancement could lead to earlier cancer diagnoses and potentially save numerous lives through timely interventions.
The IEEE conference, recognized as the world’s most important gathering in particle physics and medical imaging, will provide Crosetto with a platform to present his work to nearly 2,000 scientists. The IEEE, with its membership of over 460,000 technical professionals, has allocated Crosetto nearly two hours for his presentation, underscoring the potential impact of his research.
Despite the promising nature of Crosetto’s inventions, funding to build two 3D-CBS devices for experimental demonstration has been denied. This situation raises questions about the allocation of resources in cancer research and the challenges faced by innovative technologies in gaining support for real-world testing.
Crosetto is calling for transparency in science and has challenged his colleagues to provide references to any current or past projects that can match the potential of his inventions. He has also appealed to funding agencies, philanthropists, and government institutions to consider supporting the experimental phase of his work. With global annual spending on research and development reaching $2 trillion, Crosetto argues that a fraction of this amount could fund the construction of two 3D-CBS devices for practical testing.
The potential impact of Crosetto’s inventions extends beyond cancer detection. In the field of particle physics, the 3D-Flow technology could provide more powerful and cost-efficient tools for discovering new particles, potentially advancing our understanding of the universe.
As the conference approaches, Crosetto is urging political and social institutions to champion the cause of scientific truth for the benefit of humanity. He has reached out to various officials, including Italian politicians and the Texas Secretary of State, to appoint trusted scientists to attend his presentation and participate in public discussions comparing his inventions with other publicly funded projects aimed at reducing cancer deaths and related costs.
The presentation of Crosetto’s work at the IEEE conference represents a critical moment in the intersection of particle physics and medical imaging. If the claims about the 3D-Flow and 3D-CBS technologies are substantiated, they could mark a significant leap forward in our ability to detect cancer at its earliest stages and potentially save millions of lives while reducing healthcare costs. The scientific community and the public will be watching closely as Crosetto presents his findings, potentially ushering in a new era of cancer detection and particle physics research.